Journals / Current Research in Dental Sciences / 2015 / Supplement 10

DENTAL MANAGEMENT OF A MULTIPLE MYELOMA PATIENT: A CASE REPORT

MULTİPLE MYELOMALI HASTADA DENTAL YAKLAŞIM: OLGU SUNUMU

Pages
46–50
Publication Date
2015-05-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, the dental management of MMs has obvious clinical importance

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Multiple myeloma (MM) is a malign disease production characterized immunoglobulin (Ig) in the bone marrow.
📊
Key Findings & Data:Clinical features include recurrent bacterial infections, anemia, renal failure and osteolytic bone lesions. 5-30% of myeloma patients have been reported with jaw involvement.
💡
Conclusion & Impact:Therefore, the dental management of MMs has obvious clinical importance
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Multipl Myeloma · Fokal Enfeksiyon · Multiple Myeloma

Abstract

Multiple myeloma (MM) is a malign disease production characterized immunoglobulin (Ig) in the bone marrow. Clinical features include recurrent bacterial infections, anemia, renal failure and osteolytic bone lesions. 5-30% of myeloma patients have been reported with jaw involvement. Therefore, the dental management of MMs has obvious clinical importance

Özet

ÖZETMultipl myeloma (MM), plazma hücrelerinin kemik iliğinde anormal immunoglobulin (Ig) üretmeleri ile karakterize malign bir hastalıktır. Klinik olarak, tekrarlayan bakteriyel enfeksiyonlar, anemi, böbrek yetmezliği ve kemik iliğinde litik lezyonlar görülmekte- dir. MM olgularının %5-30’unda çenelerde belirtiler rapor edilmiştir. Bu nedenle MM hastalarında dental yaklaşım oldukça önemlidir.Bu vaka raporunun amacı, kemik iliği transp- lantasyonu (KİT) ve kemoterapi planlanan MM tanılı 30 yaşında bir erkek hastanın teşhisinde kullanılan görün- tüleme yöntemlerinin ve tedavisinin sunulmasıdır.MM hastalarında kemik iliği transplantasyon- larının başarısı, fokal enfeksiyon odakları ile ilişkili olabilmektedir. Dolayısıyla, bu hastalar kemik iliği transplan- tasyonu öncesi dental açıdan dikkatli bir şekilde değerlendirilmelidirler.Anahtar Kelimeler: Multipl Myeloma, Fokal EnfeksiyonDENTAL MANAGEMENT OF A MULTIPLE MYELOMA PATIENT: A CASE REPORTABSTRACTMultiple myeloma (MM) is a malign disease characterized by production of abnormal immunoglobulin (Ig) in the bone marrow. Clinical features include recurrent bacterial infections, anemia, renal failure and osteolytic bone lesions. 5-30% of myeloma patients have been reported with jaw involvement. Therefore, the dental management of MMs has obvious clinical importance.The aim of this case report is to present diagnostic imaging techniques and treatment of a 30-year-old man diagnosed with MM who is considering bone marrow transplantation (BMT) and chemotherapy.The success of bone marrow transplantation in MM patients may be associated with dental foci, therefore this patient must be carefully evaluated orally before bone marrow transplantation.Keywords: Multiple Myeloma, Focal Infection

🔖

Cite This Article

DEMİRTAŞ, N., AYTUĞAR, E., KAZANCIOĞLU, H. O., ERDOĞAN, E. (2015). DENTAL MANAGEMENT OF A MULTIPLE MYELOMA PATIENT: A CASE REPORT. Current Research in Dental Sciences, Supplement 10, 46–50. https://ajindex.com/articles/736011

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Yildirim M, Yildiz M, Duman E, Goktas S, Kaya V. Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer. J BUON. 2013;18:728-32.
  2. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR. Reviewof 1027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proc 2003;78:21- 33. Lemaire M, Deleu S, de Bruyne E, van Valckenborgh E, Menu E, Vanderkerken K. The microenvironment and molecular biology of the multiple myeloma tumor. Adv. Cancer Res 2012; 110:19-42.
  3. Narquin S, Ingrand P, Azais I, Delwail V, Vialle R, Boucecbi S, Tasu JP. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma. Diagn Interv Imaging 2013;94:629-36. Bersagel D. The incidence and epidemiology of plasma cell neoplasms. Stem Cells 1995; 12:1-9.
  4. Lae ME, Vencio EF, Inwards CY, Unni KK, Nascimento AG. Myeloma of the jaw bones: a clinicopathologic study of 33 cases. Head Neck 2003;25:373-81.
  5. Blomgren J, Back H. Oral hairy leukoplakia in a patient with multiple myeloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;82:408-10. Perusse R. Oral candidiasis and multiple myeloma: An unusual association. Oral Surg Oral Med Oral Pathol 1994;78:264-6.
  6. Eby C, Blinder M. Haemostatic complications associated with paraproteinemias. Curr Hematol Rep 2003;2:388-94.
  7. Kraj M, Owczarska K, Sokołowska U, Centkowski P, Pogłód R, Kruk B. Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients. Arch Immunol Ther Exp (Warsz). 2005;53:454-64.
  8. Stoopler ET, Vogl DT, Stadtmauer EA. Medical management update: multiple myeloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:599-09.
  9. Epstein JB, Voss NJ, Stevenson-Moore P. Maxillofacial manifestations of multiple myeloma: An unusual case and review of the literature. Oral Surg Oral Med Oral Pathol 1984;57:267-71.
  10. Lee SH, Huang JJ, Pan WL, Chan CP. Gingival mass as the primary manifestation of multiple myeloma. Oral Surg Oral Med Oral Pathol 1996; 82:75-9. Rolston KV. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Clin Infect Dis 2004;39(Supp 1):44-8.
  11. Shibata M, Kodani I, Doi R, Takubo K, Kidani K, Sakai H, Sonoda M, Ryoke K. Multiple myeloma presenting symptoms in the oral and maxillofac